Drinking history does not affect HCV therapy success, study finds

10/15/2012 | PhysiciansBriefing.com

Prior alcohol consumption patterns do not significantly affect the success of hepatitis C treatment using pegylated interferon-alpha and ribavirin, according to research from the Pacific Institute for Research and Evaluation in California. Data showed regardless of drinking history, 45.1% of those with HCV genotype 1, 4 or 6 and 80.2% of patients with genotype 2 or 3 achieved a sustained virological response to the combination treatment.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA